Market Synopsis of Global Acute Myeloid Leukemia Treatment
Market
Market Scenario
Acute myeloid leukemia (AML) is a cancer of the myeloid
blood cells, causing extreme and rapid growth of abnormal white blood cells of
the bone marrow. The rapid buildup of abnormal white blood cells causes
interference in the production of normal blood cells. AML has a propensity to
increase towards age. Replacement of normal bone marrow with cancer cells
causes a drop in blood constituents such as red blood cells, platelets, white blood
cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising
and bleeding, and increased risk of infection. The market driving factors for
acute myeloid leukemia (AML) are rise in risk factors such as exposures to
carcinogens such as ionizing radiation, chemicals etc. Presence of other blood
disorders and genetics is also involved for the higher risk of AML. Other
market drivers are increasing number of cancer hospitals, greater awareness,
good reimbursement scenario etc. The market constraints are poor cure rates of
the present drugs, serious side effects of the drugs etc.
Get Sample
Copy @ https://www.marketresearchfuture.com/sample_request/3223
Considering all these factors the market for acute myeloid
leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this
market is projected to growing at a CAGR of Approx 5.3 % during 2017-2023.
Figure 1 US Acute Myeloid Leukemia Treatment Market Share by Treatment, 2016 (%)
Figure 1 US Acute Myeloid Leukemia Treatment Market Share by Treatment, 2016 (%)
Key players of Global Acute Myeloid Leukemia Treatment
Market
Key players profiled in the report are Johnson & Johnson,
Pfizer Inc., Celgene Corporation, Ambit Biosciences Corporation, Cyclacel
Pharmaceuticals Inc. Novartis AG and Sanofi, Bristol Myers Squibb and others.
Segments
The global acute myeloid leukemia treatment market is
segmented on the basis of disease type. Based on the disease type, the market
has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic,
erythroleukemia and megakaryocytic. Based on the treatment, the market has been
segmented as chemotherapy, and hematopoietic stem cell transplantation.
Chemotherapy is further sub-segmented into induction and post remission.
Intended Audience
- Global acute myeloid leukemia treatment solutions
providers.
- Research and development (R&D) companies
- Market research and consulting service providers
- Academic institutes and universities
Research Methodology
Regional Analysis
US accounts for the maximum market share due to favorable
reimbursement scenario and greater expenditure on healthcare. Europe is the
second largest market due to large disposable income and presence of large
hospitals. Asia pacific region will be the fastest region because of large
unmet needs which will be led by China and India. The Middle East and Africa
market will be led by the gulf nations particularly Saudi Arabia and UAE. The
poor regions of Africa is expected to be a laggard due to poor economic and
political conditions.
The report for Global Acute myeloid leukemia treatment
Market by Market Research Future comprises of extensive primary research along
with the detail analysis of qualitative as well as quantitative aspects by
various industry experts, key opinion leaders to gain a deeper insight of the
market and industry performance. The report gives a clear picture of current
market scenario which includes past and estimated future market size with
respect to value and volume, technological advancement, macro economical and
governing factors in the market. The report provides detail information about
and strategies used by top key players in the industry. The report also gives a
broad study of the different market segments and regions.
Browse More Details @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune -
411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment